SEC Form 4 · accession 0001140361-18-033064
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew H Galligan
Officer — Chief Financial Officer
Period of report
Jul 18, 2018
Accepted (ET)
Jul 20, 2018 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 18, 2018 | M | 7,400 | $1.44 | A | 35,592 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.44 | Jul 18, 2018 | M | 7,400 | D | — | May 17, 2020 | Common Stock | 7,400 | 11,004 | D |
Explanation of responses
- F1Includes 18,125 restricted stock units.
- F2100% of the shares subject to the option are fully vested and exercisable.